Literature DB >> 9697789

Two-year stability of free and total PSA in frozen serum samples.

D Woodrum1, L York.   

Abstract

OBJECTIVES: To investigate the stability of free and total prostate-specific antigen (PSA) in serum stored at -20 degrees C and -70 degrees C for 2 years.
METHODS: Fresh blood from 29 patients was drawn and allowed to clot at room temperature. Serum was prepared by centrifugation 1 hour later and tested to determine the free and total PSA levels. Samples were aliquoted, frozen at -20 degrees C or -70 degrees C, and monitored for long-term stability over the course of 2 years.
RESULTS: On average, 91% of the free PSA, 92% of the total PSA, and 89% of the percent free PSA values were recovered after 2 years of storage at -20 degrees C; and 96% of the free PSA, 101% of the total PSA, and 95% of the percent free PSA values were recovered after 2 years of storage at -70 degrees C. Seventy percent of the samples stored at -20 degrees C and 100% of the samples stored at -70 degrees C showed no statistically significant decline in free PSA values over the 2-year period. Only one total PSA sample (-20 degrees C) showed a statistically significant loss after 2 years of storage.
CONCLUSIONS: Our results suggest that samples stored frozen for up to 2 years at -70 degrees C should give acceptable percent free PSA results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697789     DOI: 10.1016/s0090-4295(98)00156-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  The f/t-PSA ratio in diagnosis of in-patients and out-patients: a unitary cutoff value is not useful!

Authors:  C Börgermann; A Swoboda; H-J Luboldt; F vom Dorp; H Rübben
Journal:  World J Urol       Date:  2009-06-28       Impact factor: 4.226

2.  Stability of total and free prostate specific antigen in serum submitted to intermittent cold storage conditions.

Authors:  Asmahan A El Ezzi; Mohammed A El-Saidi
Journal:  Indian J Clin Biochem       Date:  2009-07-09

3.  Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.

Authors:  Carsten Stephan; Chuanliang Xu; Henning Cammann; Markus Graefen; Alexander Haese; Hartwig Huland; Axel Semjonow; Eleftherios P Diamandis; Mesut Remzi; Bob Djavan; Mark F Wildhagen; Bert G Blijenberg; Patrik Finne; Ulf-Hakan Stenman; Klaus Jung; Hellmuth-Alexander Meyer
Journal:  World J Urol       Date:  2007-02-28       Impact factor: 4.226

4.  Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.

Authors:  Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Aruna V Sarma; Cynthia J Girman; Michael M Lieber; George G Klee; Kitaw Demissie; Steven J Jacobsen
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

5.  Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration.

Authors:  S Sutcliffe; R L Nevin; R Pakpahan; D J Elliott; S R Cole; A M De Marzo; C A Gaydos; W B Isaacs; W G Nelson; L J Sokoll; J M Zenilman; S B Cersovsky; E A Platz
Journal:  Br J Cancer       Date:  2011-07-26       Impact factor: 7.640

6.  Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate.

Authors:  Shalini Agnihotri; Rama Devi Mittal; Shamim Ahmad; Anil Mandhani
Journal:  Indian J Urol       Date:  2014-01

7.  Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study.

Authors:  S E T Larkin; H E Johnston; T R Jackson; D G Jamieson; T I Roumeliotis; C I Mockridge; A Michael; A Manousopoulou; E K Papachristou; M D Brown; N W Clarke; H Pandha; C L Aukim-Hastie; M S Cragg; S D Garbis; P A Townsend
Journal:  Br J Cancer       Date:  2016-09-29       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.